CINCINNATI, May 17, 2022
/PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading
global provider of diagnostic testing solutions and life science
raw materials, announced today the continued expansion of its
isothermal amplification product line with the launch of two new
innovative master mixes, Lyo-Ready™ Direct DNA LAMP Saliva Mix and
Lyo-Ready™ Direct RNA/DNA LAMP Saliva Mix. The usage of isothermal
amplification, such as loop-mediated amplification (LAMP), is
increasing globally. The most significant increases are seen in the
point of care (POC) molecular diagnostics market and driven in part
by the COVID-19 pandemic. The constant arrival of new COVID
variants has resulted in a public demand for diagnostic assays that
offer short sample-to-result time, high sensitivity, lower cost,
and widespread accessibility.
Lyo-Ready™ Direct DNA LAMP Saliva Mix and Lyo-Ready™ Direct
RNA/DNA LAMP Saliva Mix are the first commercially available
isothermal mixes designed explicitly for saliva and sputum samples
and are compatible with lyophilization. Meridian's new master mixes
combine the benefits of high inhibitor tolerance with fast
isothermal amplification to enable ultra-sensitive detection
directly from saliva or sputum. The mixes are uniquely designed for
extraction-free amplification making them ideal for POC
diagnostics. They are compatible with lyophilization to create
ambient-temperature stable molecular diagnostic assays, providing
significant cost savings and environmental benefits in shipment and
storage.
"Isothermal amplification methods such as LAMP are increasingly
used in molecular diagnostics due to their compatibility with
point-of-care devices and fast time to results. Our newest
saliva-specific isothermal mixes are unique in the market and
outperform other commercially available master mixes with faster
time to results and significantly better amplification in terms of
sensitivity and specificity. We are confident they will quickly
become market-leading solutions for diagnostic assay developers,"
commented Lourdes Weltzien, Ph.D.
Executive Vice President – Life Science. "Saliva is an important
diagnostic specimen for a broad range of applications for detecting
bacterial or viral infections, including respiratory infections
such as COVID-19, and STDs such as HIV and herpes. Our new master
mixes can help diagnostic companies develop high-performing assays
efficiently with lower costs to the bottom line and the
environment."
Meridian is committed to supplying novel solutions to the
diagnostic industry to simplify and accelerate the development of
superior diagnostic assays. To learn more about Meridian's
innovative reagents, visit
https://www.meridianbioscience.com/lifescience/products/molecular-reagents/
or contact Paul.Marr@meridianlifescience.com.
About Meridian Bioscience, Inc.
Meridian is a fully
integrated life science company that develops, manufactures,
markets, and distributes a broad range of innovative diagnostic
products. We are dedicated to developing and delivering better
solutions that give answers with speed, accuracy, and simplicity
that are redefining the possibilities of life from discovery to
diagnosis. Through discovery and development, we provide critical
life science raw materials used in immunological and molecular
tests for human, animal, plant, and environmental applications.
Through diagnosis, we provide diagnostic solutions in areas
including gastrointestinal and upper respiratory infections and
blood lead level testing. We build relationships and provide
solutions to hospitals, reference laboratories, research centers,
veterinary testing centers, physician offices, diagnostics
manufacturers, and biotech companies in more than 70 countries
around the world.
Meridian's shares are traded on the NASDAQ Global Select Market,
symbol VIVO. Meridian's website address is
www.meridianbioscience.com.
Contact:
Charlie
Wood
Vice President – Investor Relations
Meridian Bioscience, Inc.
Phone: +1 513.271.3700
Email: mbi@meridianbioscience.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/meridian-bioscience-launches-lyo-ready-saliva-specific-isothermal-amplification-master-mixes-for-direct-detection-of-dna--rna-in-point-of-care-diagnostic-assays-301549424.html
SOURCE Meridian Bioscience, Inc.